1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2015-2019 Japan Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers

Complete report $8,800.  DataPack (test volumes, sales forecasts, supplier shares) $5,700.

“2015-2019 Japan Virology and Bacteriology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. 

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. 

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products. 

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,
Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,
Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.

Contains 976 pages and 160 tables

"2015-2019 Japan Virology and Bacteriology Testing Market" is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Table Of Contents

2015-2019 Japan Virology and Bacteriology Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers
I. Introduction

II. Major Product Development Opportunities

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Overview of Major Tests, Technologies, and Instrumentation

A. Major Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. RhinoViruses
55. RotaVirus (REOVIRUS)
56. Rubella(MEASLES)
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Automated and Semiautomated Analyzers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VII. U.K.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth, Volume by Method, and Major Suppliers' Sales and Market Shares by Test
XI. Competitive Assessments

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
XVI. Appendix: Assumed Currency Exchange Rates



List of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.K. Summary Table
All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Laboratories Performing Infectious Disease Tests by Market Segment
U.K.
Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.K.
Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.K.
All Market Segments Infectious Disease Test Volume Forecast
U.K.
All Market Segments Infectious Disease Test Volume by Method
U.K.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.K.
Blood Banks Infectious Disease Test Volume Forecast
U.K.
Public Health Laboratories Infectious Disease Test Volume Forecast
U.K.
Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.K.
All Market Segments Infectious Disease Diagnostics Market Forecast
U.K.
Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.K.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.K.
Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.K.
Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.K.
HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
AIDS Testing Market Diagnostics Sales by Major Supplier
U.K.
Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.K.
Candida Testing Market Diagnostics Sales by Major Supplier
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K.
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.K.
Influenza Testing Market Diagnostics Sales by Major Supplier
U.K.
Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K.
Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K.
RSV Testing Market Diagnostics Sales by Major Supplier
U.K.
Rubella Testing Market Diagnostics Sales by Major Supplier
U.K.
Septicemia Testing Market Diagnostics Sales by Major Supplier
U.K.
Shigella Testing Market Diagnostics Sales by Major Supplier
U.K.
Streptococci Testing Market Diagnostics Sales by Major Supplier
U.K.
Syphilis Testing Market Diagnostics Sales by Major Supplier
U.K.
Tuberculosis Testing Market Diagnostics Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.